Intermediates for the preparation of 1,3,dihydro-2H-imidazo[4,5-B]quinolin-2-one derivatives
The present invention relates to compounds of the formula (IV) wherein R represents hydrogen; C1-6alkyl; C3-6cycloalkyl; phenyl optionally substituted with from 1 to 3 substituents each independently selected from halo, hydroxy, C1-6alkyloxy, C5-6cycloalkyloxy, C1-6alkyl or trifluoromethyl; pyridiny...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
30.07.1996
|
Edition | 6 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to compounds of the formula (IV) wherein R represents hydrogen; C1-6alkyl; C3-6cycloalkyl; phenyl optionally substituted with from 1 to 3 substituents each independently selected from halo, hydroxy, C1-6alkyloxy, C5-6cycloalkyloxy, C1-6alkyl or trifluoromethyl; pyridinyl; or thienyl optionally substituted with halo or C1-6alkyl; and =C=X is a radical of the formula: =C=O (a), =C=N-O-R1 (b), or =C=CH-R2 (c); the addition salts thereof and stereochemically isomeric forms thereof, said compounds being useful as intermediate to potent inhibitors of both phosphodiesterase III and IV, which are useful in the treatment of warm-blooded animals suffering from allergic disorders, atopic diseases and related afflications.
The present invention relates to compounds of the formula (IV) wherein R represents hydrogen; C1-6alkyl; C3-6cycloalkyl; phenyl optionally substituted with from 1 to 3 substituents each independently selected from halo, hydroxy, C1-6alkyloxy, C5-6cycloalkyloxy, C1-6alkyl or trifluoromethyl; pyridinyl; or thienyl optionally substituted with halo or C1-6alkyl; and =C=X is a radical of the formula: =C=O (a), =C=N-O-R1 (b), or =C=CH-R2 (c); the addition salts thereof and stereochemically isomeric forms thereof, said compounds being useful as intermediate to potent inhibitors of both phosphodiesterase III and IV, which are useful in the treatment of warm-blooded animals suffering from allergic disorders, atopic diseases and related afflications. |
---|---|
Bibliography: | Application Number: US19950423920 |